- Confluent Medical Technologies Names Tom Testa as Chief Operating Officer
May 1, 2026 · globenewswire.com
SCOTTSDALE, Ariz., May 01, 2026 (GLOBE NEWSWIRE) -- Confluent Medical Technologies, Inc. (“Confluent”), a leading medical device and materials science contract manufacturer specializing in Nitinol and polymer components, today announced that Tom Testa, has been appointed as Chief Operating Officer ("COO") for the company, effective April 29th, 2026.
- CONFLUENT MEDICAL TECHNOLOGIES NAMES TOM TESTA AS CHIEF OPERATING OFFICER
May 1, 2026
SCOTTSDALE, ARIZ., MAY 01, 2026 (GLOBE NEWSWIRE) -- CONFLUENT MEDICAL TECHNOLOGIES, INC. (“CONFLUENT”), A LEADING MEDICAL DEVICE AND MATERIALS SCIENCE CONTRACT MANUFACTURER SPECIALIZING IN NITINOL AND POLYMER COMPONENTS, TODAY ANNOUNCED THAT TOM TESTA, HAS BEEN APPOINTED AS CHIEF OPERATING OFFICER ("COO") FOR THE COMPANY, EFFECTIVE APRIL 29TH, 2026.
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Confluent, Inc. – CFLT
Apr 21, 2026 · globenewswire.com
NEW YORK, April 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Confluent, Inc. (“Confluent” or the “Company”) (NASDAQ: CFLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
- INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF CONFLUENT, INC. – CFLT
Apr 21, 2026
NEW YORK, APRIL 21, 2026 (GLOBE NEWSWIRE) -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTORS OF CONFLUENT, INC. (“CONFLUENT” OR THE “COMPANY”) (NASDAQ: CFLT). SUCH INVESTORS ARE ADVISED TO CONTACT DANIELLE PEYTON AT NEWACTION@POMLAW.COM OR 646-581-9980, EXT. 7980.
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Confluent, Inc. - CFLT
Apr 16, 2026 · prnewswire.com
NEW YORK, April 16, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Confluent, Inc. ("Confluent" or the "Company") (NASDAQ: CFLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF CONFLUENT, INC. - CFLT
Apr 16, 2026
NEW YORK, APRIL 16, 2026 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTORS OF CONFLUENT, INC. ("CONFLUENT" OR THE "COMPANY") (NASDAQ: CFLT). SUCH INVESTORS ARE ADVISED TO CONTACT DANIELLE PEYTON AT NEWACTION@POMLAW.COM OR 646-581-9980, EXT.
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Confluent, Inc. - CFLT
Apr 14, 2026 · globenewswire.com
NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Confluent, Inc. (“Confluent” or the “Company”) (NASDAQ: CFLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
- INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF CONFLUENT, INC. - CFLT
Apr 14, 2026
NEW YORK, APRIL 14, 2026 (GLOBE NEWSWIRE) -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTORS OF CONFLUENT, INC. (“CONFLUENT” OR THE “COMPANY”) (NASDAQ: CFLT). SUCH INVESTORS ARE ADVISED TO CONTACT DANIELLE PEYTON AT NEWACTION@POMLAW.COM OR 646-581-9980, EXT. 7980.
- IBM set for in-line Q1 as Confluent deal boosts outlook
Apr 13, 2026 · proactiveinvestors.com
International Business Machines Corp (NYSE:IBM) is expected to report first-quarter results largely in line with forecasts on April 22, but Bank of America is adjusting estimates following the earlier-than-expected closing of its Confluent acquisition The bank said it anticipates an “inline quarter,” with recently acquired Confluent contributing roughly $50 million in revenue during the period after the deal closed on March 17, about one quarter earlier than previously assumed. Bank of America said IBM is likely to keep its full-year 2026 guidance unchanged, as management is expected to offset near-term dilution from the acquisition with a combination of additional revenue contribution and cost synergies.
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Confluent, Inc. - CFLT
Apr 7, 2026 · globenewswire.com
NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Confluent, Inc. (“Confluent” or the “Company”) (NASDAQ: CFLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.